Found: 10
Select item for more details and to access through your institution.
Design Features and Rationale of the BEAR-MOON (Bridge-Enhanced ACL Restoration Multicenter Orthopaedic Outcomes Network) Randomized Clinical Trial.
- Published in:
- Orthopaedic Journal of Sports Medicine, 2022, v. 10, n. 1, p. 1, doi. 10.1177/23259671211065447
- By:
- Publication type:
- Article
Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Effects of a Potent and Selective PPAR-a Agonist in Patients With Atherogenic Dyslipidemia or Hypercholesterolemia.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 12, p. 1362, doi. 10.1001/jama.297.12.1362
- By:
- Publication type:
- Article
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 171, doi. 10.1177/1479164119827604
- By:
- Publication type:
- Article
Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 306, n. 19, p. 2099, doi. 10.1001/jama.2011.1649
- By:
- Publication type:
- Article
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
- Published in:
- European Heart Journal, 2014, v. 35, n. 37, p. 2516, doi. 10.1093/eurheartj/ehu177
- By:
- Publication type:
- Article
The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE.
- Published in:
- 2020
- By:
- Publication type:
- Letter